Physician

Mark J Zalla, M.D.

According to 2025 Medicare claims, Mark Zalla, M.D. (NPI: 1356460018) practices dermatology in the Cincinnati, OH-KY-IN market, with the plurality of this provider's patient population coming from Boone, KY. This provider's primary affiliated billing organization is DERMATOLOGY ASSOCIATES OF NORTHERN KENTUCKY PSC (NPI: 1629197397; TIN: 610992991) and primary practice location at 41042-7538.

Zalla's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 244 traditional Medicare patients, billed 803 HCPCS/CPT codes, and received $186,757 in Medicare payments. The top billing code was 17311 (Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, 1-5 tissue blocks). Part D data shows 66 prescription claims across 51 beneficiaries totaling $2,311 in drug costs, led by Fluorouracil (Fluorouracil). Open Payments data shows 5 records totaling $94. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $18,559 and ending at $2,311. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$149K$298K2015 Medicare payment: $279,747 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $260,328 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $272,696 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $275,313 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $298,126 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $267,138 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $295,879 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $236,817 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $243,493 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $186,757 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20158142,583$279,747
20167622,441$260,328
20177062,405$272,696
20187182,374$275,313
20197862,709$298,126
20207252,695$267,138
20217842,918$295,879
20224781,727$236,817
20232881,034$243,493
2024244803$186,757

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$57K$114K2015 Drug cost: $18,559 (USD; Tot_Drug_Cst)2016 Drug cost: $10,754 (USD; Tot_Drug_Cst)2017 Drug cost: $10,146 (USD; Tot_Drug_Cst)2018 Drug cost: $114,226 (USD; Tot_Drug_Cst)2019 Drug cost: $21,766 (USD; Tot_Drug_Cst)2020 Drug cost: $9,572 (USD; Tot_Drug_Cst)2021 Drug cost: $14,128 (USD; Tot_Drug_Cst)2022 Drug cost: $35,344 (USD; Tot_Drug_Cst)2023 Drug cost: $5,187 (USD; Tot_Drug_Cst)2024 Drug cost: $2,311 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015108207$18,559
201684130$10,754
201776118$10,146
2018100154$114,226
2019117178$21,766
2020105169$9,572
2021148230$14,128
2022129192$35,344
202393125$5,187
20245166$2,311

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
17311Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, 1-5 tissue blocks194238$364
17313Removal and microscopic exam of growth of trunk, arms, or legs, 1-5 tissue blocks3036$351
17312Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, each additional stage, 1-5 tissue blocks5882$268
12052Intermediate repair of wound of face, ears, eyelids, nose, lips, or mouth, 2.6-5.0 cm5962$103
12032Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm3637$101

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
FluorouracilFluorouracil24625$1,684
ImiquimodImiquimod11224$150

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.5$94ABBVIE INC.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Mark J. Zalla, M.D.?

Tedicare shows public-source Medicare data for Mark J. Zalla, M.D. (NPI 1356460018), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Mark J. Zalla, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Mark J. Zalla, M.D.?

Mark J. Zalla, M.D. is linked to DERMATOLOGY ASSOCIATES OF NORTHERN KENTUCKY PSC (billing NPI 1629197397) in the available physician profile data.

Does Mark J. Zalla, M.D. have Open Payments data?

Mark J. Zalla, M.D. has 5 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.